• Corpus ID: 133494382

11- (2-pyrrolidin-1-yl - ethoxy) -14,19- dioxa -5,7,26- triaza - tetracyclo [19.3.1.1 (2, 6). 1 (8,12)] heptacosa-1 (25), 2 (26), 3,5,8,10,12 (27), 16,21,23- Dekaenkuen salt

@inproceedings{200911,
  title={11- (2-pyrrolidin-1-yl - ethoxy) -14,19- dioxa -5,7,26- triaza - tetracyclo [19.3.1.1 (2, 6). 1 (8,12)] heptacosa-1 (25), 2 (26), 3,5,8,10,12 (27), 16,21,23- Dekaenkuen salt},
  author={ウィリアム,アンソニー・デオドーニア and ダイモック,ブライアン and リー,チェン・シャ・アンジェリン},
  year={2009}
}
The present invention has been found to have improved properties 11- (2-pyrrolidin-1-yl - ethoxy) -14,19- dioxa -5,7,26- triaza - tetracyclo [19.3.1. 1 (2,6). 1 (8,12)] heptacosa-1 (25), 2 (26), for a particular salt of 3,5,8,10,12 (27), 16,21,23- Dekaen (Compound I). In particular, the present invention relates to the citrate salt of this compound. The present invention also relates to a method of use of the citrate in the treatment of pharmaceutical compositions and certain medical conditions…